Lupus systémique

Lupus systémique

  
TACCESS Trial Group. Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study.Arthritis Rheumatol. 2014 Nov;66(11):3096-104Lire le résumé
Al Maimouni H et al. Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes. Arthritis Care Res (Hoboken). 2014 Dec;66(12):1905-9Lire le résumé
Sciascia S et al. Thrombotic risk assessment in systemic lupus erythematosus: validation of the global antiphospholipid syndrome score in a prospective cohort. Arthritis Care Res (Hoboken). 2014 Dec;66(12):1915-20.Lire le résumé
Tamirou F et al. and the MAINTAIN Nephritis Trial Group. Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis. Ann Rheum Dis. 2015 Mar 10. Lire le résumé
Nishimura K et al. Neurocognitive impairment in corticosteroid-naive patients with active systemic lupus erythematosus: a prospective study. J Rheumatol. 2015 Mar;42(3):441-8 Lire le résumé
Muniz LF et al. Impact of therapy on metabolic syndrome in young adult premenopausal female lupus patients: Beneficial effect of antimalarial. Arthritis Care Res (Hoboken). 2015 Apr 1Lire le résumé
Jallouli M et al. Plaquenil Lupus Systemic Study Group. Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic lupus Erythematosus. Arthritis Rheumatol. 2015 Mayl;67(8):2176-2184. Lire le résumé
Quinlan C et al. The vascular phenotype of children with systemic lupus erythematosus. Pediatr Nephrol. 2015 May 23 Lire le résumé
Dall'Era M et al. Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the euro-lupus nephritis cohort. Arthritis Rheumatol. 2015 May;67(5):1305-13. Lire le résumé
Smith CK, Kaplan MJ. The role of neutrophils in the pathogenesis of systemic lupus erythematosus. Curr Opin Rheumatol. 2015 Sep;27(5):448-53.Lire le résumé
Durcan L et al. Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence. J Rheumatol. 2015 Nov; 42(11):2092-7Lire le résumé
Hui-Yuen JS et al. Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices. J Rheumatol. 2015 Dec;42(12):2288-95 Lire le résumé
Kalunian KC et al. A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE). Ann Rheum Dis. janv 2016;75(1):196‑202. Lire le résumé
Mok CC et al. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up. Ann Rheum Dis. janv 2016;75(1):30‑6.Lire le résumé
Lee JY et al. Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol Hoboken NJ. janv 2016;68(1):184‑90Lire le résumé
Pereira KMC et al. Low C4, C4A and C4B gene copy numbers are stronger risk factors for juvenile-onset than for adult-onset systemic lupus erythematosus. Rheumatol Oxf Engl. 22 janv 2016 Lire le résumé
Isenberg DA et al. Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, doubleblind, placebo-controlled study. Ann Rheum Dis. févr 2016;75(2):323‑31. Lire le résumé
Merrill JT et al. Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis. févr 2016;75(2):332‑40.Lire le résumé
Tselios K et al. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study. J Rheumatol. mars 2016;43(3):552‑8.Lire le résumé
Tamirou F et al. Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis. Ann Rheum Dis. mars 2016;75(3):526‑31. Lire le résumé
Gomes RC et al. Features of 847 Childhood-Onset Systemic. Lupus Erythematousus Patients in Three Age Groups at Diagnosis: A Brazilian Multicenter Study. Arthritis Care Res. 25 mars 2016Lire le résumé
Wallace DJ et al. Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study. Arthritis Care Res. avr 2016;68(4):534‑43.Lire le résumé
Banchereau R et al. Personalized
Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. Cell. 21 avr 2016;165(3):551‑65.
Lire le résumé
Medina-Quiñones CV et al. Analysis of Complete Remission in Systemic Lupus Erythematosus Patients Over a 32-Year Period. Arthritis Care Res. juill 2016;68(7):981‑7.Lire le résumé
Rovin BH et al. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis. Arthritis Rheumatol Hoboken NJ. sept 2016;68(9):2174‑83.Lire le résumé
Wallace DJ et al. Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II doseranging randomised controlled trial. Ann Rheum Dis. 26 sept 2016Lire le résumé
Michel M et al. A Randomized and Double-Blind Controlled Trial Evaluating the Safety and Efficacy of Rituximab for Warm Auto-Immune Hemolytic Anemia in Adults (the RAIHA study). Am J Hematol. 3 oct 2016Lire le résumé
Vinet É et al. Brief Report: Causes of Stillbirths in Women With Systemic Lupus Erythematosus. Arthritis Rheumatol Hoboken NJ. oct 2016;68(10):2487‑91 Lire le résumé
Khamashta M et al. Sifalimumab, an antiinterferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study. Ann Rheum Dis. nov 2016;75(11):1909‑16Lire le résumé
Singh AG et al. Risk of
Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population-Based Cohort Study. Arthritis Care Res. nov 2016;68(11):1664‑70
Lire le résumé
Hoshino A et al. Abnormal hematopoeisis and autoimmunity in human subjects with germline IKZF1 mutations. J Allergy Clin Immunol. 2016 Dec 1Lire le résumé
Ziegelasch M et al. Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts. Arthritis Res Ther. 2016 Dec 3;18(1):289Lire le résumé
Palmsten K et al. Medication use among pregnant women with systemic lupus erythematosus and general population comparators. Rheumatology (Oxford). 2016 Dec 24.Lire le résumé
Cardoso F. Autoimmune choreas. J Neurol Neurosurg Psychiatry. 2016 Dec 1. pii: jnnp-2016-314475. Lire le résumé
Werth Victoria P. et al. “Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Subjects with Discoid Lupus Erythematosus.” Arthritis & Rheumatology (Hoboken, N.J.), January 24, 2017.Lire le résumé
Sciascia, S. et al. “Efficacy of Belimumab on Renal Outcomes in Patients with Systemic Lupus Erythematosus: A Systematic Review.” Autoimmunity Reviews, January 29, 2017. doi:10.1016/j.autrev.2017.01.010.Lire le résumé
Kahwage PP et al. Uveitis in childhood-onset systemic lupus erythematosus patients: a multicenter survey. Clin Rheumatol. 2017 Jan 9. Lire le résumé
Iaccarino L, et al. Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2017 Jan;69(1):115-123.Lire le résumé
Sopeña B et al. Clinical association between Kikuchi ׳s disease and systemic lupus erythematosus: A systematic literature review. Semin Arthritis
Rheum. 2017 Jan 29.
Lire le résumé
Furie et al. Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. Arthritis Rheumatol. 2017 Feb;69(2):376-386Lire le résumé
Ahn SS et al. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome. Semin Arthritis Rheum. 2017 Feb 8Lire le résumé
Tamirou F et al. The low-dose intravenous cyclophosphamide Euro-Lupus regimen does not impact the ovarian reserve, as measured by serum anti-Müllerian hormone levels. Arthritis Rheumatol Hoboken NJ. 2017 Feb 24Lire le résumé
Bundhun PK et al. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: A meta-analysis of studies published between years 2001-2016. J Autoimmun. 2017 Feb 27Lire le résumé
Asgari N et al. Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study. Mult Scler Houndmills Basingstoke Engl. 2017 Mar 1Lire le résumé
Arkema EV et al. Stroke in systemic lupus erythematosus: a Swedish population-based cohort study. Ann Rheum Dis. 2017 Apr 11Lire le résumé
Steri M et al. Overexpression of the Cytokine BAFF and
Autoimmunity Risk. N Engl J Med. 2017 27;376(17):1615–26.
Lire le résumé
Ordi-Ros J et al. Entericcoated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial. Ann Rheum Dis. 2017 Apr 27Lire le résumé
Reddy V et al. Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins. Arthritis Care Res. 2017 Jun;69(6):857–66. Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins. Arthritis Care Res. 2017 Jun;69(6):857–66Lire le résumé
van der Meulen PM et al. Protein array autoantibody profiles to determine diagnostic markers for neuropsychiatric systemic lupus erythematosus. Rheumatol Oxf Engl. 2017 Apr 27Lire le résumé
Barbhaiya M et al. Race/Ethnicity and Cardiovascular Events among Patients with Systemic Lupus Erythematosus. Arthritis Rheumatol Hoboken NJ. 2017 Jun 9Lire le résumé
Bialas AR et al. Microglia-dependent synapse loss in type I interferon-mediated lupus. Nature. 2017 Jun 22;546(7659):539–43Lire le résumé
Md Yusof MY et al. Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus
erythematosus. Ann Rheum Dis. 2017 Jul 6
Lire le résumé
Barsalou J et al. Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study. Rheumatol Oxf Engl. 2017 Jun 8Lire le résumé
Retour sur une année d’essais thérapeutiques dans le LS - Août 2017Lire le résumé
Yelin E et al. A Prospective Study of the Impact of Current Poverty, History of Poverty, and Exiting Poverty on Accumulation of Disease Damage in Systemic Lupus Erythematosus. Arthritis Rheumatol Hoboken NJ. 2017 Aug;69(8):1612–22Lire le résumé
Kaplowitz ET et al. Socioeconomic Status Contributes to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes among Women with Systemic Lupus Erythematosus. Arthritis Care Res. 2017 May 8Lire le résumé
Gergianaki I et al. Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the
community-based lupus registry of Crete, Greece. Ann Rheum Dis. 2017 Aug 5
Lire le résumé
Martin M et al. [Systemic lupus erythematosus and lymphopenia: Clinical and pathophysiological features]. Rev Med Interne. 2017 Sep;38(9):603–13.Lire le résumé
Hachulla E et al. Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry. Chest. 2017 Aug 26Lire le résumé
Fu R et al. Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis. Arthritis Rheumatol Hoboken NJ. 2017 Aug;69(8):1636–46Lire le résumé
Dall’Era M et al. The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project. Arthritis Rheumatol Hoboken NJ. 2017 Oct;69(10):1996–2005Lire le résumé
Izmirly PM et al. The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program. Arthritis Rheumatol Hoboken NJ. 2017 Oct;69(10):2006–17Lire le résumé
Bennett MR. et al. Effects of age and gender on reference levels of biomarkers
comprising the pediatric Renal Activity Index for Lupus Nephri
tis (p-RAIL). Pediatr Rheumatol Online J. 2017 Oct 13;15(1):74.
Lire le résumé
Zhang F. et al. A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea. Ann Rheum Dis. 2018 Jan 2.Lire le résumé
Hogan J et al. Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis. Pediatr Nephrol. 2018 Jan;33(1):111-116.Lire le rLire le résumé
K. Sacré et al. Impaired long-term immune protection following pneumococcal 13-valent/23-valent polysaccharide vaccine in systemic lupus erythematosus Ann Rheum Dis, published on February 14, 2018Lire le résumé
Richard Furie et al. Long-term safety and efficacy of belimumab in patients with systemic lupus
erythematosus : a continuation of the Phase 3 united States BLISS-76 trial. Arthritis and
Rheumatology published online February 2, 2018
Lire le résumé
Mimi Kim et al. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid syndrome Ann Rheum Dis published on January 25, 2018Lire le résumé
Zhi-Wei Lai et al. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to,
or intolerant of, conventional medications: a single
-
arm, open
-
label, phase 1/2 trial. The Lancet,
published online March 15, 2018
Lire le résumé
Ingeborg M. Bajema et al. Revision of the International Society of Nephrology / Renal Pathology
Society classification for lupus nephritis: classification of definitions, and modified Nat
ional Institutes of
health activity and chronicity indices. Kidney Int published online 16 February 2018
Lire le résumé
Cheng LE, Amoura Z, Cheah B, Hiepe F, Sullivan BA, Zhou L, et al. A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis. Arthritis & Rheumatology, 2018 March 7Lire le résumé
Doria A, Stohl W, Schwarting A, Okada M, Scheinberg M, van Vollenhoven R, et al. Efficacy and safety of subcutaneous belimumab in anti-dsDNA-positive, hypocomplementemic patients with systemic lupus erythamatosus, Arthritis & Rheumatology, 2018 April 18Lire le résumé
Eudy AM, Siega-Riz AM, Engel SM, Franceschini N, Howard AG, Clowse MEB, et al. Effect of pregnancy on disease flares in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases, 2018 February 20Lire le résumé
Autoimmune une Diseases in Patients with Cutaneous Lupus Erythematosis, Elaine Kunzler, Linda Hynan
and benjamin Chong, JAMA Dermatology, published online May2, 2018
Lire le résumé
Rashidi A, Fisher SI. Clinical Images: Lupus erythematosus cell. Arthritis & Rheumatology. 2018 May
14


Nakamura H, Fujieda Y, Yasuda S, Nakai M, Atsumi T. Remission of Nephrotic Syndrome After Therapy for Chronic Hepatitis C Virus Infection in a Patient With Systemic Lupus Erythematosus. Ann
Intern Med. 2018 May 1;


Sciascia Sciascia SS, Rubini E, Radin M, Cecchi I, Rossi D, Roccatello D. Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab. Annals of the Rheumatic Diseases. 2018 May 18;
annrheumdis-2018-213496.
Lire le résumé
Moroni G, Vercelloni PG, Quaglini S, Gatto M, Gianfreda D, Sacchi L, et al. Changing patterns in
clinical–histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Annals of the Rheumatic Diseases. 2018 May 5;annrheumdis-2017-
212732
Lire le résumé
Estrada K, Whelan CW, Zhao F, Bronson P, Handsaker RE, Sun C, et al. A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica. Nature Communications. 2018 DecLire le résumé
Md Yusof MY, Psarras A, El-Sherbiny YM, Hensor EMA, Dutton K, Ul-Hassan S, et al. Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. Annals of the Rheumatic Diseases. 2018 Jun 21;annrheumdis-2018-213386. Lire le résumé
Londoño Jimenez A, Mowrey WB, Putterman C, Buyon J, Goilav B, Broder A. Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated with Tubulointerstitial Inflammation and Renal Scarring. Arthritis & Rheumatology [Internet]. 2018 May 31Lire le résumé
Kato Y, Park J, Takamatsu H, Konaka H, Aoki W, Aburaya S, et al. Apoptosis-derived membrane vesicles drive the cGAS–STING pathway and enhance type I IFN production in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 2018 Jun 26;annrheumdis-2018-212988. Lire le résumé
Wallace DJ, Furie RA, Tanaka Y, Kalunian KC, Mosca M, Petri MA, et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet. 2018 Jul;392(10143):222–31. Lire le résumé
Mosca M, Costenbader KH, Johnson SR, Lorenzoni V, Sebastiani GD, Hoyer BF, et al. How Do Patients with Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria. Arthritis & Rheumatology [Internet]. 2018 Jul 23 [cited 2018 Aug 28]Lire le résumé
De Rosa M, Azzato F, Toblli JE, De Rosa G, Fuentes F, Nagaraja HN, et al. A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy. Kidney International [Internet]. 2018 Jul [cited 2018 Aug 28]Lire le résumé
De Rosa M, Azzato F, Toblli JE, De Rosa G, Fuentes F, Nagaraja HN, et al. A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy. Kidney International [Internet]. 2018 Jul [cited 2018 Aug 28]Lire le résumé
Jorge A, Wallace ZS, Zhang Y, Lu N, Costenbader KH, Choi HK. All-Cause and Cause-Specific Mortality Trends of End-Stage Renal Disease due to Lupus Nephritis from 1995 to 2014. Arthritis & Rheumatology [Internet]. 2018 Sep 18 [cited 2018 Sep 26]; Available from: http://doi.wiley.com/10.1002/art.40729

Roberts AL, Kubzansky LD, Malspeis S, Feldman CH, Costenbader KH. Association of Depression With Risk of Incident Systemic Lupus Erythematosus in Women Assessed Across 2 Decades. JAMA Psychiatry [Internet] 2018 Sep 12 [cited 2018 Sep 26]; Available from: http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/jamapsychiatry.2018.2462



Fardet L, Nazareth I, Petersen I. Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer’s disease: a population-based cohort study. Annals of the Rheumatic Diseases. 2018 Sep 5;annrheumdis-2018-214016.
Lire le résumé
Yap DYH, Tam CH, Yung S, Wong S, Tang CSO, Mok TMY, et al. Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis. Nephrology Dialysis Transplantation [Internet]. 2018 Sep 11 [cited 2018 Sep 26]; Available from: https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfy284/5094973Lire le résumé
van Vollenhoven RF, Hahn BH, Tsokos GC, Wagner CL, Lipsky P, Touma Z, et al. Efficacy and safety of
ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results
of a multicentre, double-blind, phase 2, randomised, controlled study. The Lancet [Internet]. 2018 Sep
[cited 2018 Sep 27]; Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673618321676
Lire le résumé
Rovin BH, Solomons N, Pendergraft WF, Dooley MA, Tumlin J, Romero-Diaz J, et al. A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis. Kidney International [Internet]. 2018 Nov [cited 2018 Nov 28]; Available from: https://linkinghub.elsevier.com/retrieve/pii/S0085253818306288Lire le résumé
Gaffar RPineau CA, Bernatsky S, Scott S, Vinet E. Risk of Ocular Anomalies in Children Exposed in Utero to Antimalarials: A Systematic Literature Review. Arthritis Care & Research [Internet]. 2018 Nov 12 [cited 2018 Nov 28]; Available from: http://doi.wiley.com/10.1002/acr.23808 Lire le résumé
Kelley BP, Corrigan JJ, Patel SC, Griffith BD. Neuropsychiatric Lupus with Antibody-Mediated Striatal Encephalitis. American Journal of Neuroradiology [Internet]. 2018 Nov 22 [cited 2018 Nov 28]; Available from: http://www.ajnr.org/lookup/doi/10.3174/ajnr.A5842 Lire le résumé
Hanly JGLi Q, Su L, Urowitz MB, Gordon C, Bae S-C, et al. Psychosis in Systemic Lupus Erythematosus. Arthritis & Rheumatology [Internet]. 2018 Oct 30 [cited 2018 Nov 28]; Available from: http://doi.wiley.com/10.1002/art.40764 Lire le résumé
Sciascia S, Yazdany J, Dall’Era M, Fenoglio R, Radin M, Aggarwal I, et al. Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study. Annals of the Rheumatic Diseases. 2018 Dec 14;annrheumdis-2018-214559Lire le résumé
Giannakou I, Chatzidionysiou K, Magder LS, Györi N, van Vollenhoven R, Petri MA. Predictors of persistent disease activity and long quiescence in systemic lupus erythematosus: results from the Hopkins Lupus Cohort. Lupus Science & Medicine. 2018 Nov;5(1):e000287Lire le résumé
Hasni S, Gupta S, Davis M, Poncio E, Temesgen-Oyelakin Y, Joyal E, et al. Safety and Tolerability of Omalizumab, A Randomized Clinical Trial of Humanized anti-IgE Monoclonal Antibody in Systemic Lupus Erythematosus ( STOP LUPUS ). Arthritis & Rheumatology [Internet]. 2018 Dec 29 [cited 2019 Jan 22]; Available from: http://doi.wiley.com/10.1002/art.40828Lire le résumé
Scherlinger M, Carcaud C, Truchetet M-E, Barnetche T, Duffau P, Couzi L, et al. Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study. Annals of the Rheumatic Diseases. 2019 Jan 4;annrheumdis-2018-214833Lire le résumé
Qian J, Li M, Zhang X, Wang Q, Zhao J, Tian Z, et al. Long-Term Prognosis of Patients with Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension: CSTAR-PAH Cohort Study. European Respiratory Journal. 2019 Jan 11;1800081Lire le résumé
Wither JE, Prokopec SD, Noamani B, Chang N-H, Bonilla D, Touma Z, et al. Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms. Zhou X, editor. PLOS ONE. 2018 May 9; 13(5):e0196117Lire le résumé
Wallace DJ, Ginzler EM, Merrill JT, Furie RA, Stohl W, Chatham WW, et al. Safety and efficacy of belimumab plus standard therapy for up to 13 years in patients with systemic lupus erythematosus. Arthritis & Rheumatology [Internet]. 2019 Feb 16 [cited 2019 Feb 19]; Available from: http://doi.wiley.com/10.1002/art.40861Lire le résumé
Furie R, Furie R, Werth VP, Merola JF, Stevenson L, Reynolds TL, Naik H, et al. Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus. Journal of Clinical Investigation [Internet]. 2019 Feb 18 [cited 2019 Feb 19]; Available from: https://www.jci.org/articles/view/124466Lire le résumé
Jorge A, Jorge A, Wallace ZS, Lu N, Zhang Y, Choi HK. Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort Study. Annals of Internal Medicine. 2019 Feb 19;170(4):240Lire le résumé
Tedeschi SK, Johnson SR, Boumpas DT, Daikh D, Dörner T, Diamond B, et al. Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 28 janv 2019;annrheumdis-2018-214685.Lire le résumé
Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 29 mars 2019;annrheumdis-2019-215089Lire le résumé
Li TH, Lai C-C, Wang W-H, Chen W-S, Tsao Y-P, Tsai C-Y, et al. Risk of severe herpes simplex virus infection in systemic lupus erythematosus: analysis of epidemiology and risk factors analysis in Taiwan. Ann Rheum Dis. 6 avr 2019;annrheumdis-2018-214844Lire le résumé
Cassia MA, Alberici F, Jones RB, Smith RM, Casazza G, Urban ML, et al. Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients. Arthritis Rheumatol [Internet]. 18 mai 2019 [cité 28 mai 2019]; Disponible sur: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40932Lire le résumé
Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, et al. Exostosin 1/Exostosin 2–Associated Membranous Nephropathy. J Am Soc Nephrol. 6 mai 2019;ASN.2018080852Lire le résumé